William Petri, University of Virginia As millions of people are recovering from COVID-19, an unanswered question is the extent to which the virus can “hide out” in seemingly recovered individuals. If it does, could this explain some of the lingering symptoms of COVID-19 or pose a risk for transmission of infection to others even…
Kristin Lunz Trujillo, University of Minnesota and Matt Motta, Oklahoma State University The availability of a vaccine for the novel coronavirus will likely play a key role in determining when Americans can return to life as usual. Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, on April 30 announced…
Bruce Y. Lee, City University of New York The U.S. is pinning its hopes on a COVID-19 coronavirus vaccine, but will a vaccine alone be enough to stop the pandemic and allow life to return to normal? The answer depends on a how “good” the vaccine ends up being. In a study published July…
Don Pelton As someone who is a member of at least four demographic groups associated with a higher risk of death from Corona virus, I’m distressed to live in the least vaccine-compliant county in California. The scientific understanding of the Corona virus is changing rapidly, and the degree of vaccine compliance required to achieve…
Liangfang Zhang, University of California San Diego The Research Brief is a short take about interesting academic work. The big idea Researchers around the world are working frantically to develop COVID-19 vaccines meant to target and attack the SARS-CoV-2 virus. Researchers in my nanoengineering lab are taking a different approach toward stopping SARS-CoV-2. Instead…